MAPK14 and breast carcinoma: CCL20 promotes self-renewal and maintenance of breast cancer stem cells and breast cancer stem-like cells by activating p65 nuclear factor kappa B (NF-κB) via protein kinase C or p38 mitogen-activated protein kinase.